These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4072967)

  • 1. Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies.
    Francis CW; Malone JE; Marder VJ
    Am J Clin Pathol; 1985 Dec; 84(6):724-9. PubMed ID: 4072967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
    Duncan A; Bowie EJ; Owen CA; Fass DN
    Clin Chem; 1985 Jun; 31(6):853-5. PubMed ID: 3995763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory.
    de Metz M; van Wersch JW
    Haemostasis; 1987; 17(5):254-9. PubMed ID: 3666583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
    Burns ER; Goldberg SN; Wenz B
    Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
    Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
    Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a fully automated chromogenic method for prothrombin time compared with a conventional coagulation method.
    Tripodi A; Mannucci PM
    Clin Chem; 1984 Aug; 30(8):1392-5. PubMed ID: 6744595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
    Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
    Tripodi A; Arbini A; Chantarangkul V; Mannucci PM
    Thromb Haemost; 1992 Jan; 67(1):42-5. PubMed ID: 1615481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
    d'Audigier C; Delassasseigne C; Robert A; Eschwège V
    Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
    Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
    Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin time sensitivity and specificity to mild clotting factor deficiencies of the extrinsic pathway: evaluation of eight commercial thromboplastins.
    Massignon D; Moulsma M; Bondon P; Debize G; Abidi H; Buttin T; Bon C; Pillonchery G; Coeur P
    Thromb Haemost; 1996 Apr; 75(4):590-4. PubMed ID: 8743184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
    Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Hornykewycz S; Michitsch A; Huber K; Clemens D; Susan M; Pabinger I; Eichinger S; Jilma B; Speiser W
    Thromb Res; 1997 Sep; 87(5):431-40. PubMed ID: 9306617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogenic substrates for activated partial thromboplastin time testing: are they worth using?
    Tripodi A
    Ric Clin Lab; 1989; 19(4):355-8. PubMed ID: 2517351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.